Scilex Holding Company Other Long-term Debt, Current
Scilex Holding Company (SCLX) had Other Long-term Debt, Current of $15.92 million as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:OtherLongTermDebtCurrent · last filed 2023-08-11
- 2023-06-30: Other Long-term Debt, Current $15.92M.
- 2022-12-31: Other Long-term Debt, Current $0.00.
| Period end | Other Long-term Debt, Current |
|---|---|
| 2023-06-30 | $15.92M 10-Q · filed 2023-08-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |